Immunic IMUX
NASDAQ IMUX
$7.96 -0.68 (-7.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunic (IMUX) Asset Writedowns and Impairment (2018 - 2022)

Updated

Immunic (IMUX) posted Asset Writedowns and Impairment of $33 million for Q4 2022.

Analysis

Immunic (IMUX) Asset Writedowns and Impairment (2018 - 2022) Analysis & Trends

For FY2022, Immunic's Asset Writedowns and Impairment came in at $32.97 million.

  • Annual Asset Writedowns and Impairment shows a four-year compound annual growth rate of 128.0% (FY2018 to FY2022).
  • In prior years, Immunic's Asset Writedowns and Impairment was $1.22 million in FY2018.
  • The Q4 2022 figure stands as the lowest quarterly Asset Writedowns and Impairment since Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Immunic 338.41 Mn 338.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 33.00 Mn
Sep 30, 2018 1.22 Mn
API Access

Immunic Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=IMUX&period=max&api_key=YOUR_API_KEY